| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.46▼ | 1.45▲ | 1.46▲ | 1.41▲ | 1.44▲ |
| MA10 | 1.46▲ | 1.45▲ | 1.43▲ | 1.55▼ | 1.51▼ |
| MA20 | 1.46▲ | 1.42▲ | 1.42▲ | 1.41▲ | 1.36▲ |
| MA50 | 1.45▲ | 1.40▲ | 1.47▼ | 1.47▼ | 1.55▼ |
| MA100 | 1.42▲ | 1.50▼ | 1.49▼ | 1.33▲ | 1.57▼ |
| MA200 | 1.40▲ | 1.47▼ | 1.44▲ | 1.49▼ | 4.11▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.004▲ | 0.013▲ | -0.009▼ | 0.027▲ |
| RSI | 54.436▲ | 58.651▲ | 55.068▲ | 50.346▲ | 50.665▲ |
| STOCH | 69.444 | 52.994 | 81.694▲ | 24.160 | 40.087 |
| WILL %R | -50.000 | -22.727▲ | -20.000▲ | -64.235 | -53.846 |
| CCI | 51.483 | 83.665 | 95.465 | -27.192 | 0.008 |
|
Friday, January 10, 2025 01:04 PM
NEW YORK and BERLIN, Jan. 10, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company ...
|
|
Friday, January 10, 2025 01:04 PM
NEW YORK and BERLIN, Jan. 10, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company ...
|
|
Friday, January 10, 2025 06:11 AM
Biopharmaceutical company atai Life Sciences N.V. (ATAI) announced Friday key leadership appointments to advance its goal of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/01/25 | 1.39 | 1.4892 | 1.3863 | 1.46 | 961,550 |
| 16/01/25 | 1.46 | 1.48 | 1.36 | 1.39 | 711,718 |
| 15/01/25 | 1.40 | 1.50 | 1.39 | 1.44 | 1,460,836 |
| 14/01/25 | 1.43 | 1.43 | 1.30 | 1.33 | 1,297,540 |
| 13/01/25 | 1.51 | 1.52 | 1.375 | 1.42 | 1,276,077 |
| 10/01/25 | 1.58 | 1.5988 | 1.4401 | 1.50 | 2,485,629 |
| 08/01/25 | 1.75 | 1.82 | 1.61 | 1.62 | 2,128,877 |
| 07/01/25 | 1.80 | 1.905 | 1.72 | 1.76 | 2,565,091 |
| 06/01/25 | 1.85 | 1.909 | 1.7547 | 1.78 | 3,521,220 |
| 03/01/25 | 1.65 | 1.77 | 1.59 | 1.77 | 3,036,781 |
|
|
||||
|
|
||||
|
|